(Q43002349)

English

Cost Effectiveness of Paricalcitol versus a non-selective vitamin D receptor activator for secondary hyperparathyroidism in the UK: a chronic kidney disease markov model

scientific article published in January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Cost Effectiveness of Paricalcitol versus a non-selective vitamin D receptor activator for secondary hyperparathyroidism in the UK: a chronic kidney disease markov model (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

hyperparathyroidism

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

secondary hyperparathyroidism

1 reference

based on heuristic

inferred from title

0 references

author name string

Mark Nuijten

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Dennis L Andress

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Steven E Marx

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Alistair S Curry

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Raimund Sterz

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

545-557

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

1 reference

https://api.crossref.org/works/10.2165%2F11536310-000000000-00000

21 January 2018

Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progressive vascular calcification with necrosis of extremities in hemodialysis patients: a possible role of iron overload

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic kidney disease Markov model comparing paricalcitol to calcitriol for secondary hyperparathyroidism: a US perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost of cardiovascular diseases in the United Kingdom

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inclusion of albumin as a target in therapy guidelines: guidelines for chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcitriol in the management of secondary hyperparathyroidism of renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of excess PTH on nonclassical target organs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intravenous alfacalcidol on lymphocyte phenotyping in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmented polymorphonuclear chemiluminescence in patients with secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The selection of data sources for use in modelling studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markov models in medical decision making: a practical guide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoparathyroidism potentiates cardiovascular complications through disturbed calcium metabolism: possible risk of vitamin D(3) analog administration in dialysis patients with end-stage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current medical management of secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health economics studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of fluvoxamine in the treatment of recurrent depression in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired phagocytosis in chronic renal failure is mediated by secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life and estimates of utility in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for proteinuria in US adults: a cost-effectiveness analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20586517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11536310-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43002349&oldid=1976349991"